跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
抑那通 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Leuprorelin Acetate Microspheres for Injection
Approved
化学药品
Leuprorelin Acetate Microspheres for Injection
TAKEDA PHARMACEUTICAL COMPANY LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Oct 29, 2024
Approval ID
8fGd6GFMCj8
Company
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Type
化学药品
Approval Details
Approval Id
8fGd6GFMCj8
Approval Number
国药准字HJ20150326
Generic Name
注射用醋酸亮丙瑞林微球
Generic Name En
Leuprorelin Acetate Microspheres for Injection
Trade Name
抑那通
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.88mg
Reg Date
2024-10-29
Expired Date
2029-10-28
Company Name
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Company Detail Path
/organization/takeda-pharmaceutical-company-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 29, 2024
Approval ID
8fGd6GFMCj8
Type
化学药品
Back to NMPA Approvals
